CG
CALC icon

Cutler Group’s CalciMedica CALC Stock Holding History

Cutler Group’s Portfolio CALC Stock Details CALC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-2,143
Closed -$11K – 5737
2021
Q2 		$11K Buy
+2,143
New +$141K ﹤0.01% 3787

Other funds holding CALC

DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
ACM
Aisling Capital Management New York $476M AUM 128.63% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
BCM
BML Capital Management Zionsville, Indiana $156M AUM 129.82% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
MPM
Meritage Portfolio Management Overland Park, Kansas $1.51B AUM 26.61% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Cutler Group's CALC Position: Q1 2024 in Review

Cutler Group sold out of CalciMedica (CALC) in Q1 2024, closing a stake of 14 shares.

Cutler Group first reported a position in CALC in Q2 2021 and held it in 10 quarters. The position peaked at $28K in Q2 2021. 20 funds tracked by Wall St. Rank hold CALC as of Q1 2024.

  • Cutler Group reported no remaining CalciMedica position as of Q1 2024 after selling out during the quarter.
  • Cutler Group sold 14 CalciMedica shares in Q1 2024.
  • Cutler Group first reported a position in CalciMedica in Q2 2021 and held it in 10 quarters.
  • Cutler Group's CalciMedica position peaked at $28K in Q2 2021.
  • 20 funds tracked by Wall St. Rank held CalciMedica as of Q1 2024.

Based on Cutler Group's 13F filing for Q1 2024, filed 19 Apr 2024.